1. Sato, S., Takahashi, S., Asamoto, M., Naiki, T., Naiki-Ito, A., Asai, K., Shirai, T.: Tranilast suppresses prostate cancer growth and osteoclast differentiation in vivo and in vitro. Prostate, 70:229-238, 2010.
2. Takahashi, S., Imai, N., Nabae, K., Wake, K., Kawai, H., Wang, J., Watanabe, S., Kawabe, M., Fujiwara, O., Ogawa, K., Tamano, S., Shirai, T.: Lack of adverse effects of whole-body exposure to a mobile telecommunication electromagnetic field on the rat fetus. Radiation Res, 173:362-372, 2010.
3. Naiki-Ito, A., Asamoto, M., Naiki, T., Ogawa, K., Takahashi, S., Sato, S., Shirai, T.: Gap junction dysfunction reduces acetaminophen hepatotoxicity with impact on apoptotic signaling and connexin 43 protein induction in rat. Toxicol Pathol, 38: 280-286, 2010.
4. Suzuki, S., Takeshita, K., Doi, Y., Asamoto, M., Takahashi, S., Naiki-Ito, A., Shirai, T.: 2-Amino-3,8-dimethylimidazo[4,5-f]quinoline (MeIQx)-induced hepatocarcinogenesis is not enhanced by CYP1A inducers, alpha- and beta-naphthoflavone; relationship to interlobular distribution of CYP1A expression. Toxicol Pathol, 38:568-582, 2010.
5. Kubota, E., Kataoka, H., Aoyama, M., Mizoshita, T., Mori, Y., Shimura, T., Sasaki, M., Takahashi, S., Asai, K., Joh, T.: Role of ES cell-expressed Ras, ERas in tumorigenicity of gastric cancer. Am J Pathol, 177:955-963, 2010.
6. Pitchakarn, P., Ogawa, K., Suzuki, S., Takahashi, S., Asamoto, M., Chewonarin, T., Limtrakul, P., Shirai, T.: Momordica Charantia leaf extract suppresses rat prostate cancer progression in vitro and in vivo. Cancer Sci, 101:2234-2240, 2010.
7. Tsuda, H., Futakuchi, M., Fukamachi, K., Shirai, T., Imaida, K., Fukushima, S., Tatematsu, M., Furukawa, F., Tamano, S., Ito, N.: A medium-term, rapid rat bioassay model for the detection of carcinogenic potential of chemicals. Toxicol Pathol, 38: 182-187, 2010.
8. Yamaguchi, T., Kanemitsu, H., Yamamoto, S., Komatsu, M., Uemura, H., Tamura, K., Shirai, T.: N,N’-bis(2-chloroethyl)- N-nitrosourea (BCNU)-induced apoptosis of neural progenitor cells in the developing fetal rat brain. J Toxicol Pathol, 23: 25-30, 2010.
9. Ichikawa, K., Tagawa, Y., Kawai, M., Asamoto, M., Shirai, T.: Promoting effects of streptozotocin-induced diabetes on Induction of hepatic preneoplastic Lesions by diethylnitrosamine in rats. J Toxicol Pathol, 23: 125-131, 2010.
10. Niida, H., Murata, K., Shimada, M., Ogawa, K., Ohta, K., Suzuki, K., Fujigaki, H., Khaw, AK., Banerjee, B., Hande, M., Miyamoto, T., Miyoshi, I., Shirai, T., Motoyama, N., Delhase, M., Appella, E., Nakanishi, M.: Cooperative functions of Chk1 and Chk2 reduce tumour susceptibility in vivo. EMBO J, 29: 3558-3570, 2010.
11. Yachida, S., Imaida, K., Yokohira, M., Hashimoto, N., Suzuki, S., Okano, K., Wakabayashi, H., Maeta, H., Suzuki, Y.: Jun activation domain binding protein 1 is overexpressed from the very early stages of hepatocarcinogenesis. Ann Surg Oncol, 17: 3386-3393, 2010.
12. Yokohira, M., Arnold, LL., Pennington, KL., Suzuki, S., Kakiuchi-Kiyota, S., Herbin-Davis, K., Thomas, DJ., Cohen, SM.: Severe systemic toxicity and urinary bladder cytotoxicity and regenerative hyperplasia induced by arsenite in arsenic (+3 oxidation state) methyltransferase knockout mice. A preliminary report. Toxicol Appl Pharmacol, 246: 1-7, 2010.
13. Suzuki, S., Arnold, LL., Pennington, KL., Chen, B., Naranmandura, H., Le, XC., Cohen, SM.: Dietary administration of sodium arsenite to rats: relations between dose and urinary concentrations of methylated and thio-metabolites and effects on the rat urinary bladder epithelium. Toxicol Appl Pharmacol, 244: 99-105, 2010.
14. Suzuki, S., Arnold, LL., Pennington, KL., Kakiuchi-Kiyota, S., Wei, M., Wanibuchi, H., Cohen, SM.: Effects of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on the urine and urothelium of the rat. Toxicol Sci, 113: 349-357, 2010.